• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec29
Eli Lilly and Company to Pay First-Quarter 2026 Dividend
02:42
Eli Lilly Initiates Phase II Clinical Trial for Brenipatide in Moderate to Severe Asthma
00:00
U.S. fitness and food industries adapt as GLP-1 weight-loss drugs go mainstream
00:00
Dec28
Eli Lilly's oral weight-loss drug Orforglipron is anticipated to receive FDA approval in Q1 2026
20:00
Eli Lilly is no longer a 'boring' stock, has transformed into a 'real growth stock,' says investor
14:03
Nvwm LLC Reduces Holdings in Eli Lilly
11:06

Schedules & Filings

Schedules
Filings
Feb13
Distribution Plan(EST)

Cash dividend 1.73 USD

Distribution Plan(EST)

Cash dividend 1.73 USD

Dec10
Distribution Plan(EST)

Cash dividend 1.5 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
24.010
+78.91%
+10.590
PCLA
0.4050
+74.49%
+0.173
DTCK
0.3951
+66.08%
+0.157
SOPA
1.820
+58.26%
+0.670
ECDA
1.150
+46.50%
+0.365
GAUZ
1.470
+44.12%
+0.450
CELG.RT
0.0698
+39.60%
+0.020
ASPCR
0.2500
+38.89%
+0.070
PAVS
2.170
+37.34%
+0.590
CUE
0.3248
+34.77%
+0.084
View More